Stay updated on eNERGY Clinical Trial: Nivo/Ipi vs Chemo in PS 2/Elderly
Sign up to get notified when there's something new on the eNERGY Clinical Trial: Nivo/Ipi vs Chemo in PS 2/Elderly page.

Latest updates to the eNERGY Clinical Trial: Nivo/Ipi vs Chemo in PS 2/Elderly page
- Check3 days agoChange DetectedThe record describes a completed Phase 3 trial comparing nivolumab plus ipilimumab with carboplatin-based chemotherapy for certain patients with advanced non-small cell lung cancer. It includes eligibility criteria, study locations, treatment arms and outcomes, record dates, publications, and study documents.SummaryDifference60%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide notice about NIH terminology during a transition was added, and the displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, indicating access to the record is blocked. This change reduces the ability to view the study information and related documents.SummaryDifference18%

- Check59 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a new page version. The change represents an internal update to the page template and related backend content management, with no explicit study details modified.SummaryDifference0.0%

Stay in the know with updates to eNERGY Clinical Trial: Nivo/Ipi vs Chemo in PS 2/Elderly
Enter your email address, and we'll notify you when there's something new on the eNERGY Clinical Trial: Nivo/Ipi vs Chemo in PS 2/Elderly page.